Evidence map›Paper›PMID 32751832›Full record

ReviewInternational journal of molecular sciences2020

Sialylated Immunoglobulins for the Treatment of Immuno-Inflammatory Diseases.

Yuliya V Markina, Elena V Gerasimova, Alexander M Markin, Victor Y Glanz, Wei-Kai Wu, Igor A Sobenin, Alexander N Orekhov

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. The Association of the Polymorphisms in theInternational journal of molecular sciences · 2023
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 2 countries.

Yuliya V MarkinaLaboratory of Cellular and Molecular Pathology of the Cardiovascular System, Institute of Human Morphology, 3 Tsyurupy Street, 117418 Moscow, Russia.ORCID 0000-0002-3781-6340
Elena V GerasimovaDepartment of Systemic Rheumatic Diseases, V.A. Nasonova Research Institute of Rheumatology, 34A Kashirskoe Shosse, 115522 Moscow, Russia.ORCID 0000-0001-5815-561X
Alexander M MarkinLaboratory of Cellular and Molecular Pathology of the Cardiovascular System, Institute of Human Morphology, 3 Tsyurupy Street, 117418 Moscow, Russia.ORCID 0000-0002-6649-7924
Victor Y GlanzLaboratory of Cellular and Molecular Pathology of the Cardiovascular System, Institute of Human Morphology, 3 Tsyurupy Street, 117418 Moscow, Russia.
Wei-Kai WuDepartment of Internal Medicine, National Taiwan University Hospital, Bei-Hu Branch, Taipei 108, Taiwan.ORCID 0000-0002-9476-8998
Igor A SobeninLaboratory of Cellular and Molecular Pathology of the Cardiovascular System, Institute of Human Morphology, 3 Tsyurupy Street, 117418 Moscow, Russia.ORCID 0000-0003-0978-6444
Alexander N OrekhovLaboratory of Cellular and Molecular Pathology of the Cardiovascular System, Institute of Human Morphology, 3 Tsyurupy Street, 117418 Moscow, Russia.ORCID 0000-0002-3318-4681
Research Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences · RUResearch Institute of Human Morphology · RUAssociation of Rheumatologists of Russia · RUInstitute of Experimental Cardiology · RUNational Taiwan University Hospital · TW

Funding

Russian Science Foundation Grant № 20-15-00264
6 · The paper itself

Abstract

Immunoglobulins are the potent effector proteins of the humoral immune response. In the course of evolution, immunoglobulins have formed extremely diverse types of molecular structures with antigen-recognizing, antigen-binding, and effector functions embedded in a single molecule. Polysaccharide moiety of immunoglobulins plays the essential role in immunoglobulin functioning. There is growing evidence that the carbohydrate composition of immunoglobulin-linked glycans, and especially their terminal sialic acid residues, provide a key effect on the effector functions of immunoglobulins. Possibly, sialylation of Fc glycan is a common mechanism of IgG anti-inflammatory action in vivo. Thus, the post-translational modification (glycosylation) of immunoglobulins opens up significant possibilities in the diagnosis of both immunological and inflammatory disorders and in their therapies. This review is focused on the analysis of glycosylation of immunoglobulins, which can be a promising addition to improve existing strategies for the diagnosis and treatment of various immuno-inflammatory diseases.

Indexed as

Immunoglobulin GAnimalsGlycosylationHumansImmune System DiseasesImmunoglobulin Fc FragmentsInflammationMiceN-Acetylneuraminic AcidPolysaccharidesProtein Processing, Post-TranslationalImmunoglobulin Fc FragmentsImmunoglobulin GN-Acetylneuraminic AcidPolysaccharidesatherosclerosisimmunoglobulinsimmuno-inflammatory diseasesinflammationsialidasesialylation

Identifiers

PMID32751832
PMCPMC7432344
OpenAlexW3046567466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.